Stone House Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$168K Buy
1,400
+161
+13% +$18.6K 0.03% 91
2025
Q4
$130K Buy
1,239
+71
+6% +$6.67K 0.02% 103
2025
Q3
$98K Buy
1,168
+8
+0.7% +$659 0.02% 115
2025
Q2
$91.8K Buy
1,160
+10
+0.9% +$795 0.02% 110
2025
Q1
$103K Buy
+1,150
New +$107K 0.02% 92
2024
Q4
Sell
-1,150
Closed -$131K 236
2024
Q3
$131K Sell
1,150
-25
-2% -$2.97K 0.03% 63
2024
Q2
$145K Buy
+1,175
New +$151K 0.04% 62

Other funds holding MRK

Stone House Investment Management's MRK Position: Q1 2026 in Review

Stone House Investment Management increased its Merck (MRK) stake by 13% in Q1 2026, buying an estimated $18.6K and bringing the position to 1,400 shares worth $168K. The position accounts for 0.03% of the portfolio, ranked #91.

Stone House Investment Management first reported a position in MRK in Q2 2024 and has held it in 7 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Stone House Investment Management held 1,400 shares of Merck worth $168K as of Q1 2026.
  • Stone House Investment Management bought 161 Merck shares in Q1 2026, an estimated $18.6K.
  • Merck made up 0.03% of Stone House Investment Management's portfolio in Q1 2026, its #91 holding.
  • Stone House Investment Management first reported a position in Merck in Q2 2024 and has held it in 7 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Stone House Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.